查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1831767

CRISPR与Cas遗传基因市场，规模，占有率，趋势，产业分析报告:各产品，各类服务，各用途，各最终用途，各地区 - 2025年～2034年的市场预测

CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report By Product (Kits & Enzymes, Libraries), By Service, By Application, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，CRISPR 和 Cas 基因市场规模将达到 214.6 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

CRISPR 和 Cas 基因是指用于基因编辑的天然细菌防御系统。 CRISPR 序列引导 Cas 酶到达特定的 DNA 位置，从而实现精确切割。

CRISPR 基因编辑提供了一种可持续的农作物改良方法，以应对日益增长的粮食需求和环境挑战。 CRISPR 无需外源基因即可培育抗虫、耐旱和高产量的植物。这种精准技术有助于培育出比传统基因改造生物 (GMO) 更健康、更有营养、更受消费者和监管机构欢迎的作物。各国政府和农业公司正在大力投资以 CRISPR 为基础的作物研究，以提高粮食安全。基因编辑在农业领域的应用日益广泛，极大地推动了对 CRISPR 酶、试剂盒和试剂的需求，从而推动了全球市场的成长。

个人化医疗专注于根据个体独特的基因特征客製化治疗方案。 CRISPR 技术对于开发针对特定致病基因突变的基因疗法至关重要。随着人们对遗传疾病认识的不断提高，越来越多的患者正在寻求个人化治疗，以提高疗效并减少副作用。这一趋势推动了对基于 CRISPR 的诊断和治疗的需求，鼓励公司投资研发和产品开发。基因编辑能够为癌症、罕见疾病和遗传性疾病创建客製化解决方案，随着个人化医疗成为 CRISPR 和 Cas 基因市场的主要驱动力，市场正在不断扩大。

CRISPR 和 Cas 基因市场报告重点

由于试剂盒和酵素在促进基因编辑过程中发挥至关重要的作用，因此预计在预测期内，其复合年增长率将达到 19.1%。

2024 年，农业应用领域占市场收入的 13.11%。这得归功于对改良作物性状（例如抗虫、耐旱和高产）日益增长的需求，这些性状是应对全球粮食安全挑战的重要解决方案。

2024 年，北美将引领 CRISPR 和 Cas 基因市场，占全球收入的 45.52%，这得益于其强大的研究生态系统、雄厚的资金支持和高度发达的生物技术部门。

受生物技术研究投资增加和医疗基础设施加强的推动，亚太地区 CRISPR 和 Cas 基因市场预计在预测期内以 19.3% 的复合年增长率扩张。

全球主要市场参与者包括 Addgene、阿斯特捷利康、Caribou Biosciences, Inc.、Cellectis、CRISPR Therapeutics、丹纳赫集团、Editas Medicine, Inc.、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England BioLabs、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England BioLabs、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England BioLabs、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England BioLabs、Horizo​​​​n Discovery Group Plc、Mammoth Biosciences、New England；和 Sherlock Biosciences。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 CRISPR和Cas遗传基因市场洞察

  • CRISPR和Cas遗传基因 - 产业概述
  • CRISPR和Cas遗传基因市场动态
    • 促进因素和机会
      • CRISPR 技术创新
      • 在各领域的应用
    • 限制因素和挑战
      • 固有缺陷
  • PEST 分析
  • CRISPR 和 Cas 基因市场产业趋势
  • COVID-19 的影响分析

第5章 联络处资讯

  • 取得技术许可的联络方式
    • Wellcome Trust Sanger Institute, Cambridge, UK
    • The Innovative Genomics Initiative, California
    • Thermo Fisher Scientific, Waltham, Massachusetts
    • the Broad Institute and Whitehead Institute
    • ERS Genomics Ltd
    • Merck KGaA
    • Oxford Genetics Limited
    • Caribou Biosciences, Inc.
    • CRISPR Therapeutics
    • Sherlock Biosciences
    • US Berkeley
  • 基因编辑技术的契约金额

第6章 CRISPR与Cas遗传基因市场评估:各产品及服务

  • 简介
  • 产品
  • 服务

第7章 CRISPR与Cas遗传基因市场评估:各用途

  • 简介
  • 生物医学
  • 农业

第8章 CRISPR与Cas遗传基因市场评估:各最终用途

  • 简介
  • 生物科技及製药公司
  • 学术机构及政府调查机关
  • 契约调查机关(CRO)

第9章 CRISPR与Cas遗传基因市场评估:各地区

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 奥地利
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东·非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国

第10章 竞争情形

  • 产品销售和合作，是被企业最僱用的策略。
  • 产品销售
  • 联盟/合作/协定/公开

第11章 企业简介

  • Addgene
  • AstraZeneca
  • Caribou Biosciences, Inc.
  • Cellectis
  • CRISPR Therapeutics
  • Danaher Corporation
  • Editas Medicine, Inc.
  • Horizon Discovery Group Plc
  • Mammoth Biosciences
  • New England BioLabs
Product Code: PM1738

The CRISPR & cas genes market size is expected to reach USD 21.46 billion by 2034, according to a new study by Polaris Market Research. The report "CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report By Product (Kits & Enzymes, Libraries), By Service, By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

CRISPR-Cas genes refer to a natural bacterial defense system used for gene editing. The CRISPR sequences guide the Cas enzyme to specific DNA locations to make precise cuts.

CRISPR gene editing offers a sustainable way to improve crops with increasing food demand and environmental challenges. It enables the development of pest-resistant, drought-tolerant, and higher-yielding plants without introducing foreign genes. This precision technology helps create healthier, more nutritious crops that meet consumer and regulatory preferences better than traditional genetically modified organisms (GMOs). Governments and agricultural companies invest heavily in CRISPR-based crop research to improve food security. The expanding use of gene editing in agriculture significantly boosts the demand for CRISPR enzymes, kits, and reagents, driving the market's growth worldwide.

Personalized medicine focuses on tailoring treatments based on an individual's unique genetic profile. CRISPR technology is crucial for developing gene therapies that target specific genetic mutations causing diseases. More patients seek personalized treatments that improve effectiveness and reduce side effects as awareness about genetic disorders rises. This trend fuels demand for CRISPR-based diagnostics and therapeutics, encouraging companies to invest in research and product development. The market grows as gene editing enables the creation of customized solutions for cancer, rare diseases, and inherited conditions, making personalized medicine a key driver in the CRISPR & Cas genes market.

CRISPR & Cas Genes Market Report Highlights

The kits & enzymes segment is projected to register a CAGR of 19.1% during the forecast period, owing to their essential role in facilitating gene-editing processes.

In 2024, the agricultural application segment captured 13.11% of the market revenue, driven by rising demand for improved crop traits such as pest resistance, drought tolerance, and higher yield, which is a key solution to global food security challenges.

North America led the CRISPR & Cas genes market in 2024, accounting for 45.52% of the global revenue, supported by a robust research ecosystem, significant financial backing, and a highly developed biotechnology sector.

The Asia Pacific CRISPR & Cas genes market is anticipated to expand at a CAGR of 19.3% during the forecast period, fueled by growing investments in biotechnology research and the strengthening of healthcare infrastructure.

A few global key market players are Addgene, AstraZeneca, Caribou Biosciences, Inc., Cellectis, CRISPR Therapeutics, Danaher Corporation, Editas Medicine, Inc., Horizon Discovery Group Plc, Mammoth Biosciences, New England BioLabs, Wellcome Trust Sanger Institute, The Innovative Genomics Initiative, Thermo Fisher Scientific, ERS Genomics Ltd, Merck KGaA, Oxford Genetics Limited, and Sherlock Biosciences.

Polaris Market Research has segmented the CRISPR & Cas genes market report based on product, service, application, end use, and region:

By Product (Revenue - USD Billion, 2020-2034)

Kits & Enzymes

Vector-Based Cas

DNA-Free Cas

Libraries

Design Tool

Antibodies

Other Products

By Service (Revenue - USD Billion, 2020-2034)

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA Synthesis

By Application (Revenue - USD Billion, 2020-2034)

Biomedical

Agricultural

By End Use (Revenue - USD Billion, 2020-2034)

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

Chapter 1. Introduction

  • 1.1 Report Description
    • 1.1.1 Objectives of the Study
    • 1.1.2 Market Scope
    • 1.1.3 Assumptions
  • 1.2 Stakeholders

Chapter 2. Executive Summary

Chapter 3. Research Methodology

  • 3.1 Overview
    • 3.1.1 Data Mining
  • 3.2 Data Sources
    • 3.2.1 Primary Sources
    • 3.2.2 Secondary Sources

Chapter 4. CRISPR & Cas Genes Market Insights

  • 4.1 CRISPR & Cas Genes - Industry snapshot
  • 4.1 CRISPR & Cas Genes Market Dynamics
    • 4.1.1 Drivers and Opportunities
      • 4.1.1.1 Innovations in CRISPR technologies
      • 4.1.1.2 Applicability in varied areas
    • 4.1.2 Restraints and Challenges
      • 4.1.2.1 Inherent Disadvantages
  • 4.2 Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers (Moderate)
    • 4.2.2 Threats of New Entrants: (Low)
    • 4.2.3 Bargaining Power of Buyers (Low to Medium)
    • 4.2.4 Threat of Substitute (Low)
    • 4.2.5 Rivalry among existing firms (Medium to High)
  • 4.3 PEST Analysis
  • 4.4 CRISPR & Cas Genes Market Industry trends
  • 4.5 COVID-19 Impact Analysis

Chapter 5. Contact Point Information

  • 5.1 Contact Point Information for obtaining a license to use the technology
    • 5.1.1 Wellcome Trust Sanger Institute, Cambridge, UK
    • 5.1.2 The Innovative Genomics Initiative, California
    • 5.1.3 Thermo Fisher Scientific, Waltham, Massachusetts
    • 5.1.4 the Broad Institute and Whitehead Institute
    • 5.1.5 ERS Genomics Ltd
    • 5.1.6 Merck KGaA
    • 5.1.7 Oxford Genetics Limited
    • 5.1.8 Caribou Biosciences, Inc.
    • 5.1.9 CRISPR Therapeutics
    • 5.1.10 Sherlock Biosciences
    • 5.1.11 UC Berkeley
  • 5.2 The contract amount for genome editing technology

Chapter 6. CRISPR & Cas Genes Market Assessment by Product & Services

  • 6.1 Introduction
  • 6.2 Product
    • 6.2.1 Kits & Enzymes
      • 6.2.1.1 Vector-based Cas
      • 6.2.1.2 DNA-free Cas
    • 6.2.2 Libraries
    • 6.2.3 Design Tool
    • 6.2.5 Other Products
  • 6.3 Services
    • 6.3.1 Cell Line Engineering
    • 6.3.2 gRNA Design
    • 6.3.3 Microbial Gene Editing
    • 6.3.4 DNA Synthesis

Chapter 7. CRISPR & Cas Genes Market Assessment by Application

  • 7.1 Introduction
  • 7.2 Biomedical
  • 7.3 Agricultural

Chapter 8. CRISPR & Cas Genes Market Assessment by End-Use

  • 8.1 Introduction
  • 8.2 Biotechnology & Pharmaceutical Companies
  • 8.3 Academics & Government Research Institutes
  • 8.4 Contract Research Organizations (CROs)

Chapter 9. CRISPR & Cas Genes Market Assessment by Region

  • 9.1 Introduction
  • 9.2 CRISPR & Cas Genes Market - North America
    • 9.2.1 CRISPR & Cas Genes Market - U.S.
    • 9.2.2 CRISPR & Cas Genes Market - Canada
  • 9.3 CRISPR & Cas Genes Market - Europe
    • 9.3.1 CRISPR & Cas Genes Market - Germany
    • 9.3.2 CRISPR & Cas Genes Market - UK
    • 9.3.3 CRISPR & Cas Genes Market - France
    • 9.3.4 CRISPR & Cas Genes Market - Italy
    • 9.3.5 CRISPR & Cas Genes Market - Spain
    • 9.3.6 CRISPR & Cas Genes Market - Netherlands
    • 9.3.7 CRISPR & Cas Genes Market - Austria
  • 9.4 CRISPR & Cas Genes Market - Asia Pacific
    • 9.4.1 CRISPR & Cas Genes Market - China
    • 9.4.2 CRISPR & Cas Genes Market - India
    • 9.4.3 CRISPR & Cas Genes Market - Japan
    • 9.4.4 CRISPR & Cas Genes Market - South Korea
  • 9.5 CRISPR & Cas Genes Market - Latin America
    • 9.5.1 CRISPR & Cas Genes Market - Brazil
    • 9.5.2 CRISPR & Cas Genes Market - Mexico
    • 9.5.3 CRISPR & Cas Genes Market - Argentina
  • 9.6 CRISPR & Cas Genes Market - Middle East & Africa
    • 9.6.1 CRISPR & Cas Genes Market - Saudi Arabia
    • 9.6.2 CRISPR & Cas Genes Market - UAE

Chapter 10. Competitive Landscape

  • 10.1 Product Launch & Collaborations Both Are The Best Adopted Strategies by the Companies
  • 10.2 Product Launch
  • 10.3 Partnerships/Collaborations/Agreements/Exhibitions

Chapter 11. The Company Profiles

  • 11.1 Addgene
    • 11.1.1 Business Overview
    • 11.1.2 Financial Snapshot
    • 11.1.3 Products and Services
  • 11.2 AstraZeneca
    • 11.2.1 Business Overview
    • 11.2.2 Financial Snapshot
    • 11.2.3 Products and Services
    • 11.2.4 Recent Developments
  • 11.3 Caribou Biosciences, Inc.
    • 11.3.1 Business Overview
    • 11.3.2 Financial Snapshot
    • 11.3.3 Products and Services
    • 11.3.4 Recent Developments
  • 11.4 Cellectis
    • 11.4.1 Business Overview
    • 11.4.2 Financial Snapshot
    • 11.4.3 Products and Services
    • 11.4.4 Recent Developments
  • 11.5 CRISPR Therapeutics
    • 11.5.1 Business Overview
    • 11.5.2 Financial Snapshot
    • 11.5.3 Products and Services
    • 11.5.4 Recent Developments
  • 11.6 Danaher Corporation
    • 11.6.1 Business Overview
    • 11.6.2 Financial Snapshot
    • 11.6.3 Products and Services
    • 11.6.4 Recent Developments
  • 11.7 Editas Medicine, Inc.
    • 11.7.1 Business Overview
    • 11.7.2 Financial Snapshot
    • 11.7.3 Products and Services
  • 11.8 Horizon Discovery Group Plc
    • 11.8.1 Business Overview
    • 11.8.2 Financial Snapshot
    • 11.8.3 Products and Services
    • 11.8.4 Recent Developments
  • 11.9 Mammoth Biosciences
    • 11.9.1 Business Overview
    • 11.9.2 Financial Snapshot
    • 11.9.3 Products and Services
  • 11.10 New England BioLabs
    • 11.10.1 Business Overview
    • 11.10.2 Financial Snapshot
    • 11.10.3 Products and Services
  • Table 1 Contact Details: Wellcome Trust Sanger Institute
  • Table 2 Contact Details : The Innovative Genomics Initiative, California
  • Table 3 Contact Details : Thermo Fisher Scientific
  • Table 4 Contact Details : the Broad Institute and Whitehead Institute
  • Table 5 Contact Details : ERS Genomics Ltd
  • Table 6 Contact Details : Merck KGaA
  • Table 7 Contact Details : Oxford Genetics Limited
  • Table 8 Contact Details : Caribou Biosciences, Inc.
  • Table 9 Contact Details : CRISPR Therapeutics
  • Table 10 Contact Details : Sherlock Biosciences
  • Table 11 Contact Details : UC Berkeley
  • Table 12 Global CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 13 Global CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 14 Global CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 15 Global CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 16 Global CRISPR & Cas Genes Market, by Product, 2020 - 2034 (USD Million)
  • Table 17 Global CRISPR & Cas Genes Market, by Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 18 Global CRISPR & Cas Genes Market, by Vector-based Cas, 2020 - 2034 (USD Million)
  • Table 19 Global CRISPR & Cas Genes Market, by DNA-free Cas, 2020 - 2034 (USD Million)
  • Table 20 Global CRISPR & Cas Genes Market, by Libraries, 2020 - 2034 (USD Million)
  • Table 21 Global CRISPR & Cas Genes Market, by Design Tool, 2020 - 2034 (USD Million)
  • Table 22 Global CRISPR & Cas Genes Market, by Antibodies, 2020 - 2034 (USD Million)
  • Table 23 Global CRISPR & Cas Genes Market, by Other Products, 2020 - 2034 (USD Million)
  • Table 24 Global CRISPR & Cas Genes Market, by Services, 2020 - 2034 (USD Million)
  • Table 25 Global CRISPR & Cas Genes Market, by Cell Line Engineering, 2020 - 2034 (USD Million)
  • Table 26 Global CRISPR & Cas Genes Market, by gRNA Design, 2020 - 2034 (USD Million)
  • Table 27 Global CRISPR & Cas Genes Market, by Microbial Gene Editing, 2020 - 2034 (USD Million)
  • Table 28 Global CRISPR & Cas Genes Market, by DNA Synthesis, 2020 - 2034 (USD Million)
  • Table 29 Global CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 30 Global CRISPR & Cas Genes Market, by Biomedical, 2020 - 2034 (USD Million)
  • Table 31 Global CRISPR & Cas Genes Market, by Agricultural, 2020 - 2034 (USD Million)
  • Table 32 Global CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 33 Global CRISPR & Cas Genes Market, by Biotechnology & Pharmaceutical Companies, 2020 - 2034 (USD Million)
  • Table 34 Global CRISPR & Cas Genes Market, by Academics & Government Research Institutes, 2020 - 2034 (USD Million)
  • Table 35 Global CRISPR & Cas Genes Market, by Contract Research Organizations (CROs), 2020 - 2034 (USD Million)
  • Table 36 CRISPR & Cas Genes Market Assessment, By Geography, 2020 - 2034 (USD Million)
  • Table 37 North America CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 38 North America CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 39 North America CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 40 North America CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 41 North America CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 42 North America CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 43 U.S. CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 44 U.S. CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 45 U.S. CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 46 U.S. CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 47 U.S. CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 48 U.S. CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 49 Canada CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 50 Canada CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 51 Canada CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 52 Canada CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 53 Canada CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 54 Canada CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 55 Europe CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 56 Europe CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 57 Europe CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 58 Europe CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 59 Europe CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 60 Europe CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 61 Germany CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 62 Germany CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 63 Germany CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 64 Germany CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 65 Germany CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 66 Germany CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 67 UK CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 68 UK CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 69 UK CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 70 UK CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 71 UK CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 72 UK CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 73 France CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 74 France CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 75 France CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 76 France CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 77 France CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 78 France CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 79 Italy CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 80 Italy CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 81 Italy CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 82 Italy CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 83 Italy CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 84 Italy CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 85 Spain CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 86 Spain CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 87 Spain CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 88 Spain CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 89 Spain CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 90 Spain CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 91 Netherlands CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 92 Netherlands CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 93 Netherlands CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 94 Netherlands CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 95 Netherlands CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 96 Netherlands CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 97 Austria CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 98 Austria CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 99 Austria CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 100 Austria CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 101 Austria CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 102 Austria CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 103 Asia Pacific CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 104 Asia Pacific CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 105 Asia Pacific CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 106 Asia Pacific CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 107 Asia Pacific CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 108 Asia Pacific CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 109 China CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 110 China CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 111 China CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 112 China CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 113 China CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 114 China CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 115 India CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 116 India CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 117 India CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 118 India CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 119 India CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 120 India CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 121 Japan CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 122 Japan CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 123 Japan CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 124 Japan CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 125 Japan CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 126 Japan CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 127 South Korea CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 128 South Korea CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 129 South Korea CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 130 South Korea CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 131 South Korea CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 132 South Korea CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 133 Latin America CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 134 Latin America CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 135 Latin America CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 136 Latin America CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 137 Latin America CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 138 Latin America CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 139 Brazil CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 140 Brazil CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 141 Brazil CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 142 Brazil CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 143 Brazil CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 144 Brazil CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 145 Mexico CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 146 Mexico CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 147 Mexico CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 148 Mexico CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 149 Mexico CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 150 Mexico CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 151 Argentina CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 152 Argentina CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 153 Argentina CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 154 Argentina CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 155 Argentina CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 156 Argentina CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 157 Middle East & Africa CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 158 Middle East & Africa CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 159 Middle East & Africa CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 160 Middle East & Africa CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 161 Middle East & Africa CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 162 Middle East & Africa CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 163 Saudi Arabia CRISPR & Cas Genes Market, By Product & Services, 2020 - 2034 (USD Million)
  • Table 164 Saudi Arabia CRISPR & Cas Genes Market, By Product, 2020 - 2034 (USD Million)
  • Table 165 Saudi Arabia CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 166 Saudi Arabia CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 167 Saudi Arabia CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 168 Saudi Arabia CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Table 169 UAE CRISPR & Cas Genes Market, By Products & Services, 2020 - 2034 (USD Million)
  • Table 170 UAE CRISPR & Cas Genes Market, By Products, 2020 - 2034 (USD Million)
  • Table 171 UAE CRISPR & Cas Genes Market, By Kits & Enzymes, 2020 - 2034 (USD Million)
  • Table 172 UAE CRISPR & Cas Genes Market, By Services, 2020 - 2034 (USD Million)
  • Table 173 UAE CRISPR & Cas Genes Market, By Application, 2020 - 2034 (USD Million)
  • Table 174 UAE CRISPR & Cas Genes Market, By End-Use, 2020 - 2034 (USD Million)
  • Figure 1. Executive Summary
  • Figure 2. Research Methodology: Top Down & Bottom-Up Approach
  • Figure 3. Market by Geography, 2017 - 2028 (USD Million)
  • Figure 4. Porter's Five Forces
  • Figure 5. PEST Analysis
  • Figure 6. Market by Product & Services
  • Figure 7. Global CRISPR & Cas Genes Market, By Product & Services, 2020 & 2028 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global CRISPR & Cas Genes Market, By Application, 2020 & 2028 (USD Million)
  • Figure 10. Market by End-Use
  • Figure 11. Global CRISPR & Cas Genes Market, By End-Use, 2020 & 2028 (USD Million)
  • Figure 12. CRISPR & Cas Genes Market Assessment, By Geography, 2020 & 2028 (USD Million)
  • Figure 13. Strategic Analysis - CRISPR & Cas Genes